Maribel Yazdanifar

Stanford University, Palo Alto, USA

Mountain View, California, United States of America

Research Expertise

CAR T cells
Cancer Immunology
Immunotherapy
Tumor Biology
Protein Engineering
TCR T cells
Gene editing

About

I am a Senior Scientist with 14 years of experience in immunology, and molecular biology. My expertise focuses on T cell engineering, developing CAR- and TCR-engineered T cells for cancer therapy, TCR verification assays, CRISPR gene editing, tumor models, and gamma delta T cells.

Legacy Map

Full View

Publications

CAR‐NK cell in cancer immunotherapy; A promising frontier
Cancer Science
2021
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Frontiers in Immunology
2019
γδ T Cells: The Ideal Tool for Cancer Immunotherapy
Cells
2020
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Stem Cell Research & Therapy
2021
RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Frontiers in Oncology
2021
A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis
Oncogene
2016
Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
Cells
2019
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
Stem Cell Research & Therapy
2021
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells
Archives of Medical Research
2013
Hurdles to breakthrough in CAR T cell therapy of solid tumors
Stem Cell Research & Therapy
2022
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
BMC Cancer
2018
Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors
Translational Oncology
2016
Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products
Pharmaceutical Research
2021
Making a case for using γδ T cells against SARS-CoV-2
Critical Reviews in Microbiology
2020
Abstract 2305: Tumor MUC1 glycoprotein-highly specific CAR T cells control triple-negative breast cancer
Immunology
2019
Strengthening the CAR‐T cell therapeutic application using CRISPR/Cas9 technology
Biotechnology and Bioengineering
2021
The Effect of Carrier Type on Bone Regeneration of Demineralized Bone Matrix In Vivo
Journal of Craniofacial Surgery
2013
Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
Frontiers in Cell and Developmental Biology
2022
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
Frontiers in Immunology
2021
Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
Cancer Cell International
2021
Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy
Journal of Bioactive and Compatible Polymers
2022
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives
Expert Review of Clinical Immunology
2022
Controversial role of γδ T cells in pancreatic cancer
International Immunopharmacology
2022
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Frontiers in Immunology
2020
Reconstructing the cell–cell interaction network among mouse immune cells
Biotechnology and Bioengineering
2023
Abstract A37: Development and future of CAR T cell therapy for pancreatic ductal adenocarcinoma and triple negative breast cancer
Cancer Research
2017
Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host
Journal of Immunotherapy
2024
Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantation
Reviews in Medical Virology
2021
Tumor -Associated MUC1 Regulates TGF-β Signaling and Function in Pancreatic Ductal Adenocarcinoma
Unknown Venue
2020
Abstract 2636: Tumor associated MUC1 mediates TGF-β in pancreatic cancer
Cancer Research
2019
The use of tMUC1 highly specific chimeric antigen receptor-redirected T cells for the eradication of triple negative breast cancer
The Journal of Immunology
2017
Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy
Frontiers in Oncology
2023
Retraction: Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy
Frontiers in Cell and Developmental Biology
2023
Abstract 2305: Tumor MUC1 glycoprotein-highly specific CAR T cells control triple-negative breast cancer
Cancer Research
2019
Abstract 584: Developing a novel engineered T cell to target resistant pancreatic cancer
Cancer Research
2019
Front Matter
Basics of Chimeric Antigen Receptor (CAR) Immunotherapy
2019
Abstract 3464: MUC1 regulates TGF-β in pancreatic cancer
Cancer Research
2018
Abstract 4708: A novel anti-MUC1 CAR T cell drives immunity to pancreatic cancer
Cancer Research
2017
Abstract 321: MUC1 regulates TGFβ function in pancreatic cancer
Cancer Research
2017
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
Cells
2020
RETRACTED: A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
Frontiers in Immunology
2021
RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
Frontiers in Immunology
2021
RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
Frontiers in Medicine
2021
RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy
Frontiers in Cell and Developmental Biology
2021

Education

University of North Carolina at Charlotte

PhD/Dr, Biological Sciences / August, 2019

Charlotte, North Carolina, United States of America

Experience

Stanford medicine

Postdoctoral scholar / November, 2019Present

Join Maribel on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts

Connect with researchers and scientists like Maribel Yazdanifar on NotedSource to help your company with innovation, research, R&D, L&D, and more.